ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 127 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $83,000 | -2.4% | 1,651 | 0.0% | 0.01% | -16.7% |
| Q1 2020 | $85,000 | -16.7% | 1,651 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $102,000 | +218.8% | 1,651 | +212.7% | 0.01% | +200.0% |
| Q3 2019 | $32,000 | -28.9% | 528 | 0.0% | 0.00% | -33.3% |
| Q2 2019 | $45,000 | -10.0% | 528 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $50,000 | +35.1% | 528 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $37,000 | -85.5% | 528 | -82.3% | 0.00% | -80.0% |
| Q3 2018 | $255,000 | -40.0% | 2,986 | -18.5% | 0.02% | -42.3% |
| Q2 2018 | $425,000 | +44.6% | 3,664 | +0.9% | 0.03% | +44.4% |
| Q1 2018 | $294,000 | +34.9% | 3,630 | -2.3% | 0.02% | +38.5% |
| Q4 2017 | $218,000 | +96.4% | 3,714 | +56.8% | 0.01% | +85.7% |
| Q3 2017 | $111,000 | +70.8% | 2,369 | +31.0% | 0.01% | +75.0% |
| Q2 2017 | $65,000 | +16.1% | 1,808 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $56,000 | +250.0% | 1,808 | +274.3% | 0.00% | +300.0% |
| Q4 2016 | $16,000 | +23.1% | 483 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $13,000 | +18.2% | 483 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $11,000 | -21.4% | 483 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $14,000 | -12.5% | 483 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $16,000 | -5.9% | 483 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $17,000 | – | 483 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 564,102 | $42,184,000 | 14.63% |
| Fairmount Funds Management LLC | 387,400 | $28,970,000 | 9.55% |
| Soleus Capital Management, L.P. | 318,275 | $23,801,000 | 2.38% |
| Darwin Global Management, Ltd. | 166,190 | $12,428,000 | 1.90% |
| Paradigm Biocapital Advisors LP | 75,507 | $5,646,000 | 1.61% |
| ARMISTICE CAPITAL, LLC | 1,056,000 | $78,968,000 | 1.29% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 150,000 | $11,217,000 | 1.29% |
| Portland Global Advisors LLC | 75,869 | $5,673,000 | 0.95% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,573,829 | $117,691,000 | 0.59% |
| Yorktown Management & Research Co Inc | 10,400 | $778,000 | 0.52% |